IL93223A0 - Formulations comprising 31-azido-31-deoxythymidine - Google Patents

Formulations comprising 31-azido-31-deoxythymidine

Info

Publication number
IL93223A0
IL93223A0 IL93223A IL9322390A IL93223A0 IL 93223 A0 IL93223 A0 IL 93223A0 IL 93223 A IL93223 A IL 93223A IL 9322390 A IL9322390 A IL 9322390A IL 93223 A0 IL93223 A0 IL 93223A0
Authority
IL
Israel
Prior art keywords
deoxythymidine
azido
formulations
Prior art date
Application number
IL93223A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523878A external-priority patent/GB8523878D0/en
Priority claimed from GB868603447A external-priority patent/GB8603447D0/en
Priority claimed from GB868603719A external-priority patent/GB8603719D0/en
Priority claimed from GB868608272A external-priority patent/GB8608272D0/en
Priority claimed from GB868615322A external-priority patent/GB8615322D0/en
Priority claimed from IL80035A external-priority patent/IL80035A0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to IL93223A priority Critical patent/IL93223A0/en
Publication of IL93223A0 publication Critical patent/IL93223A0/en

Links

IL93223A 1985-09-17 1990-01-30 Formulations comprising 31-azido-31-deoxythymidine IL93223A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL93223A IL93223A0 (en) 1985-09-17 1990-01-30 Formulations comprising 31-azido-31-deoxythymidine

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
GB858523878A GB8523878D0 (en) 1985-09-27 1985-09-27 Therapeutic compounds
GB868603447A GB8603447D0 (en) 1986-02-12 1986-02-12 Therapeutic compounds
GB868603719A GB8603719D0 (en) 1986-02-14 1986-02-14 Antiviral compounds
GB868608272A GB8608272D0 (en) 1986-04-04 1986-04-04 Antiviral combination
US87779686A 1986-06-23 1986-06-23
GB868615322A GB8615322D0 (en) 1986-06-23 1986-06-23 Antiviral combinations
IL80035A IL80035A0 (en) 1985-09-17 1986-09-15 Nucleoside derivatives,their preparation and pharmaceutical compositions containing them
IL93223A IL93223A0 (en) 1985-09-17 1990-01-30 Formulations comprising 31-azido-31-deoxythymidine

Publications (1)

Publication Number Publication Date
IL93223A0 true IL93223A0 (en) 1990-11-05

Family

ID=27571235

Family Applications (2)

Application Number Title Priority Date Filing Date
IL9322386A IL93223A (en) 1985-09-17 1986-09-15 Synergistic formulations comprising 3'azido-3'-deoxythymidine and a glucuronidation inhibitor,a renal excretion inhibitor or a nucleoside transport inhibitor
IL93223A IL93223A0 (en) 1985-09-17 1990-01-30 Formulations comprising 31-azido-31-deoxythymidine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL9322386A IL93223A (en) 1985-09-17 1986-09-15 Synergistic formulations comprising 3'azido-3'-deoxythymidine and a glucuronidation inhibitor,a renal excretion inhibitor or a nucleoside transport inhibitor

Country Status (1)

Country Link
IL (2) IL93223A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Also Published As

Publication number Publication date
IL93223A (en) 1992-02-16

Similar Documents

Publication Publication Date Title
BG47969A1 (en) Cryoultrasonic skalpel
GB2176703B (en) Novel formulation
GB8612780D0 (en) Formulation
GB8623389D0 (en) Pharmaceutical formulations
GB8428952D0 (en) Formulations
GB8513358D0 (en) Formulation
GB8529500D0 (en) Formulation
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
GB8523690D0 (en) Formulations
GB8503221D0 (en) Pharmaceutical formulations
GB8531555D0 (en) Sucrose-free formulations
GB8521705D0 (en) Formulation
GB8521704D0 (en) Formulation
GB8524812D0 (en) Formulation
GB8506703D0 (en) Formulation
GB8500591D0 (en) Formulation
CA54057S (en) Mini-kiosk
CA54075S (en) Footbag
CA54277S (en) Footbag
GB8428951D0 (en) Formulations
GB8606755D0 (en) Formulations
GB8606455D0 (en) Formulations
GB8521863D0 (en) Pharmaceutical formulations
GB8524653D0 (en) Pharmaceutical formulations
IE852129L (en) Pellet formulations